Nu Skin Enterprises (NUS) Tops Q4 EPS by 1c, Beats on Revenue; Offers FY18 EPS Outlook Below Consensus, FY18 Revenue Guidance Above Consensus

Nu Skin Enterprises (NYSE: NUS) reported Q4 EPS of $1.20, $0.01 better than the analyst estimate of $1.19. Revenue for the quarter came in at $666.2 million versus the consensus estimate of $665.44 million.

GUIDANCE:

Nu Skin Enterprises sees FY2018 EPS of $3.45-$3.65, versus the consensus of $3.65. Nu Skin Enterprises sees FY2018 revenue of $2.44-2.49 billion, versus the consensus of $2.37 billion.

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c